Suppr超能文献

斯洛伐克患者对使用仿制药的体验及仿制药替代情况的态度。

Patients attitudes towards experience with use of generics in Slovakia, performance of generic substitution.

作者信息

Palagyi M, Lassanova M

机构信息

The Slovak Generic Association (GENAS), Bratislava, Slovakia.

出版信息

Bratisl Lek Listy. 2008;109(7):324-8.

Abstract

BACKGROUND

Generic substitution of branded pharmaceuticals is a widely adopted tool among payers to achieve cost savings. The adoption and safe use of generics among consumers is predicated upon their knowledge of and attitudes toward these products.

OBJECTIVES

The aims of this study were to assess patients' attitudes towards generic drugs and their experience with using generics, identify factors associated with differences in attitudes and/or experience, and discern the rate of generic substitution in Slovakia.

METHODS

Two thousand questionnaires were distributed to patients via pharmacies throughout Slovakia by eleven pharmaceutical companies representing GENAS (the Slovak Generic Association). Responses were received from 1,777 persons (88.85% response rate). Demographic information of respondents was also acquired.

RESULTS

Only 33.8% (600/1773) of respondents care to know about the product which they are using. Over one half (61.1%, 1084/1774) of respondents indicated no distrust in using generics, with many of them indicating a preference for a product with a lower co-payment.

CONCLUSION

About 1/3 of patients care to know whether they are using generic or branded pharmaceuticals. If there is a lack of information about generics, this could inhibit the use of generics by patients and discern a rate of generic substitution (Tab. 3, Fig. 1, Ref. 18).

摘要

背景

品牌药品的仿制药替代是支付方广泛采用的一种节省成本的手段。消费者对仿制药的接受和安全使用取决于他们对这些产品的了解和态度。

目的

本研究旨在评估患者对仿制药的态度及其使用仿制药的经历,确定与态度和/或经历差异相关的因素,并了解斯洛伐克仿制药替代的比例。

方法

代表斯洛伐克仿制药协会(GENAS)的11家制药公司通过斯洛伐克各地的药店向患者发放了2000份问卷。共收到1777人的回复(回复率为88.85%)。还收集了受访者的人口统计学信息。

结果

只有33.8%(600/1773)的受访者关心他们正在使用的产品。超过一半(61.1%,1084/1774)的受访者表示在使用仿制药时没有不信任感,其中许多人表示更喜欢自付费用较低的产品。

结论

约1/3的患者关心自己是否正在使用仿制药或品牌药。如果缺乏关于仿制药的信息,这可能会抑制患者对仿制药的使用,并影响仿制药替代率(表3,图1,参考文献18)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验